Pascal Hammel
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research 213
- Lung Cancer Research Studies 34
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 68
- Epidemiology top 0.2%
- Neuroendocrine Tumor Research Advances 106
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 34
- Surgery top 0.2%
- Pancreatitis Pathology and Treatment 92
- Gastrointestinal disorders and treatments 29
-
- Renal cell carcinoma treatment 31
- Co-authors
- Philippe RuszniewskiAlain SauvanetAnne CouvelardPhilippe LévyDermot O’TooleChristophe LouvetThierry AndréP Bernadès
- Cited by
- OncologyCancer ResearchEpidemiology
- Journals
- Journal of Clinical Oncology (58 papers)Pancreatology (18 papers)Gastroenterology (17 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Pascal Hammel
352 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 12.1k
- Cancer Research 2.9k
- Epidemiology 5.8k
- Neurology 2.3k
- Surgery 5.7k
Countries citing papers authored by Pascal Hammel
This map shows the geographic impact of Pascal Hammel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Hammel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Hammel more than expected).
Fields of papers citing papers by Pascal Hammel
This network shows the impact of papers produced by Pascal Hammel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Hammel. The network helps show where Pascal Hammel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pascal Hammel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 31 | |
| 13 | 2019 | 5 | |
| 14 | 2014 | 27 | |
| 15 | 2011 | 28 | |
| 16 | Evaluation of Progression-Free Survival by Blinded Independent Central Review in Patients With Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors Treated With Sunitinib or Placebo | 2011 | 2 |
| 17 | 2011 | 12 | |
| 18 | 2005 | 1 | |
| 19 | 1998 | 19 | |
| 20 | 1997 | 73 |
About Pascal Hammel
Pascal Hammel is a scholar working on Oncology, Cancer Research and Epidemiology, having authored 367 papers that have together received 15.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (213 papers), Neuroendocrine Tumor Research Advances (106 papers), Pancreatitis Pathology and Treatment (92 papers), Cancer Genomics and Diagnostics (68 papers), Neuroblastoma Research and Treatments (34 papers), Lung Cancer Research Studies (34 papers), Renal cell carcinoma treatment (31 papers) and Gastrointestinal disorders and treatments (29 papers). The work is most often cited by research in Oncology (12.1k citations), Cancer Research (2.9k citations) and Epidemiology (5.8k citations). Pascal Hammel has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Philippe Ruszniewski, Alain Sauvanet, Anne Couvelard, Philippe Lévy, Dermot O’Toole, Christophe Louvet, Thierry André, P Bernadès, Olivia Hentic and Frédérique Maire. Their work appears in journals such as Journal of Clinical Oncology, Pancreatology, Gastroenterology, Annals of Oncology and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.